Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook ...
IT’S hard not to notice the amount of male celebrities who have stepped out sporting a much slimmer frame and chiselled ...
The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...
Everyday Health on MSN
Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS
Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...
Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...
The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...
Medpage Today on MSN
Does Microdosing GLP-1s Work? Expert Weighs In
For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...
India Today on MSN
Maker of blockbuster weight-loss drug Mounjaro ties up with Cipla to reach small-town India
US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...
GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Orlando restaurant is set to ...
As GLP-1 medications curb appetites nationwide, will restaurants adapt to smaller cravings? Medications like Ozempic, Mounjaro and Wegovy, originally prescribed for diabetes, are now widely used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback